SG11201606237RA - Hcv chimeric vaccine with influenza virus as vector and preparation method thereof - Google Patents

Hcv chimeric vaccine with influenza virus as vector and preparation method thereof

Info

Publication number
SG11201606237RA
SG11201606237RA SG11201606237RA SG11201606237RA SG11201606237RA SG 11201606237R A SG11201606237R A SG 11201606237RA SG 11201606237R A SG11201606237R A SG 11201606237RA SG 11201606237R A SG11201606237R A SG 11201606237RA SG 11201606237R A SG11201606237R A SG 11201606237RA
Authority
SG
Singapore
Prior art keywords
vector
preparation
influenza virus
chimeric vaccine
hcv chimeric
Prior art date
Application number
SG11201606237RA
Inventor
Penghui Yang
Shaogeng Zhang
Xiliang Wang
Yueqiang Duan
Peirui Zhang
Zhiwei Li
Zhaohai Wang
Original Assignee
Beijing 302 Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing 302 Hospital filed Critical Beijing 302 Hospital
Publication of SG11201606237RA publication Critical patent/SG11201606237RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16041—Use of virus, viral particle or viral elements as a vector
    • C12N2760/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG11201606237RA 2014-01-28 2014-06-13 Hcv chimeric vaccine with influenza virus as vector and preparation method thereof SG11201606237RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410041509.0A CN103757032B (en) 2014-01-28 2014-01-28 A kind of HCV chimerics with influenza virus as carrier and preparation method thereof
PCT/CN2014/000580 WO2015113187A1 (en) 2014-01-28 2014-06-13 Hcv chimeric vaccine with influenza virus as vector and preparation method thereof

Publications (1)

Publication Number Publication Date
SG11201606237RA true SG11201606237RA (en) 2016-09-29

Family

ID=50524351

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201606237RA SG11201606237RA (en) 2014-01-28 2014-06-13 Hcv chimeric vaccine with influenza virus as vector and preparation method thereof

Country Status (3)

Country Link
CN (1) CN103757032B (en)
SG (1) SG11201606237RA (en)
WO (1) WO2015113187A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103757032B (en) * 2014-01-28 2017-06-06 中国人民解放军第三0二医院 A kind of HCV chimerics with influenza virus as carrier and preparation method thereof
CN105330730A (en) * 2014-07-29 2016-02-17 中国科学院上海巴斯德研究所 Preparation and application of hepatitis C virus recombinant protein
CN109097341B (en) * 2018-08-28 2021-09-24 青岛农业大学 Replication-defective recombinant influenza virus capable of simultaneously expressing HA and HEF

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1317559T1 (en) * 2000-04-28 2009-04-30 St Jude Childrens Res Hospital Dna transfection system for the generation of infectious negative strand rna virus
DE10143490C2 (en) * 2001-09-05 2003-12-11 Gsf Forschungszentrum Umwelt Recombinant MVA with the ability to express HCV structural antigens
CN102154226B (en) * 2011-01-10 2012-10-17 南方医科大学 Chimeric virus of complete envelope protein of HCV (hepatitis C virus) and GB virus B
CN103316357B (en) * 2013-02-05 2016-04-13 中国人民解放军军事医学科学院微生物流行病研究所 Recombinant influenza chimeric carrying RSV gene and preparation method thereof
CN103757032B (en) * 2014-01-28 2017-06-06 中国人民解放军第三0二医院 A kind of HCV chimerics with influenza virus as carrier and preparation method thereof

Also Published As

Publication number Publication date
CN103757032B (en) 2017-06-06
CN103757032A (en) 2014-04-30
WO2015113187A1 (en) 2015-08-06

Similar Documents

Publication Publication Date Title
HK1255847A1 (en) Vaccines against hepatitis b virus
ZA201700165B (en) Influenza virus vaccines and uses thereof
SG10201913630YA (en) Zika virus vaccine
HUE061679T2 (en) Zika virus vaccine
IL251450A0 (en) Compositions and methods for silencing hepatitis b virus gene expression
SI3718565T1 (en) Respiratory virus vaccines
HK1223110A1 (en) Influenza virus vaccines and uses thereof
SG11201610443WA (en) Influenza virus vaccines and uses thereof
EP3119883A4 (en) Influenza virus vectors and uses therefor
EP3247389A4 (en) Influenza virus vaccination regimens
GB201613191D0 (en) Zika virus vaccine
SG11201702116VA (en) Viral rna segments as immunomodulatory agents and vaccine components
IL263550A (en) Vaccine against infectious bronchitis virus
SG11201701256RA (en) Vaccine compositions against dengue virus diseases
IL247185B (en) Tilapia lake virus vaccines
HK1255379A1 (en) Hepatitis c virus immunogenic compositions and methods of use thereof
SG11201704942QA (en) Dengue virus vaccine compositions and methods of use thereof
SG11201606237RA (en) Hcv chimeric vaccine with influenza virus as vector and preparation method thereof
GB201605099D0 (en) HCV vaccines
IL249705B (en) Influenza virus vaccines and uses thereof
IL249704A0 (en) Influenza virus vaccines and uses thereof
GB201702193D0 (en) Hepatitis E virus vaccine
PT3393510T (en) Zika virus vaccine
GB201408046D0 (en) Virus preparations